Recruiting Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression NCT07155226 Conditions Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Bone Marrow Diseases, +15 more Locations Research Site — Decatur, Illinois, United States Research Site — New York, United States Research Site — Chapel Hill, North Carolina, United States Research Site — Durham, North Carolina, United States View all 30 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes NCT06196203 Conditions Higher-risk Myelodysplastic Syndromes Locations UCLA Ronald Reagan Medical Center — Los Angeles, California, United States Rocky Mountain Cancer Centers — Aurora, Colorado, United States Yale Cancer Center — New Haven, Connecticut, United States Mid Florida Hematology and Oncology Center — Orange City, Florida, United States View all 15 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS NCT06471946 Conditions Higher-risk Myelodysplastic Syndromes Locations Navy General Hospital — Beijing, Beijing Municipality, China View Trial Details
